首页> 外文期刊>The international journal of artificial organs >Extracorporeal membrane oxygenation treatment for H1N1-induced acute respiratory distress syndrome (ARDS): Results of the croatian referral center for respiratory ECMO
【24h】

Extracorporeal membrane oxygenation treatment for H1N1-induced acute respiratory distress syndrome (ARDS): Results of the croatian referral center for respiratory ECMO

机译:H1N1诱发的急性呼吸窘迫综合征(ARDS)的体外膜氧合作用:克罗地亚呼吸道ECMO转诊中心的结果

获取原文
获取原文并翻译 | 示例

摘要

Introduction: Extracorporeal membrane oxygenation (ECMO) has been effective in the treatment of H1N1-induced ARDS across the globe. However, the evidence supporting the use of ECMO in ARDS is still being collected. The intention of this study was to add a piece of puzzle to the growing body of evidence on the use of ECMO in ARDS patients.Methods: The study included adult patients with H1N1-induced ARDS treated with ECMO at the University Hospital for Infectious Diseases in Zagreb, Croatia between October 2009 and December 2013.Results: 17 patients with H1N1-induced ARDS treated with ECMO were included in the study. The patient cohort of the study was young with a median age of 43 years (range 23-74). The hospital mortality was 35%. Possible variables associated with mortality were analyzed and only hemolysis was found to be significant.Conclusions: Our results confirm the usefulness of ECMO treatment in patients with H1N1-induced ARDS.
机译:简介:体外膜氧合(ECMO)在全球范围内已有效治疗H1N1引起的ARDS。但是,仍在收集支持在ARDS中使用ECMO的证据。该研究的目的是为越来越多的证据表明在ARDS患者中使用ECMO的证据越来越多。方法:该研究纳入了在纽约大学传染病医院接受ECMO治疗的H1N1诱导的ARDS成年患者。结果:2009年10月至2013年12月,克罗地亚萨格勒布。结果:该研究纳入了17例接受ECMO治疗的H1N1致ARDS患者。该研究的患者队列年龄较小,中位年龄为43岁(范围23-74)。医院死亡率为35%。分析了与死亡率相关的可能变量,仅发现溶血是有意义的。结论:我们的结果证实了ECMO治疗对H1N1引起的ARDS的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号